A phase II trial of induction Erlotinib followed by chemotherapy with Platinum + Pemetrexed +/- Bevacizumab for EGFR mutation-positive non-squamous non-small cell lung cancer patients.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19039-e19039
Author(s):  
Tetsuo Tani ◽  
Kenzo Soejima ◽  
Katsuhiko Naoki ◽  
Daisuke Arai ◽  
Kouta Ishioka ◽  
...  
Lung Cancer ◽  
2007 ◽  
Vol 55 (1) ◽  
pp. 109-113 ◽  
Author(s):  
Alexander Schmittel ◽  
Maren Knödler ◽  
Patricia Hortig ◽  
Karsten Schulze ◽  
Eckhard Thiel ◽  
...  

Lung Cancer ◽  
2010 ◽  
Vol 70 (1) ◽  
pp. 77-81 ◽  
Author(s):  
Jaeheon Jeong ◽  
Byoung Chul Cho ◽  
Joo Hyuk Sohn ◽  
Hye Jin Choi ◽  
Se Hyun Kim ◽  
...  

Lung Cancer ◽  
2002 ◽  
Vol 35 (1) ◽  
pp. 1-7 ◽  
Author(s):  
S. Larive ◽  
P. Bombaron ◽  
R. Riou ◽  
P. Fournel ◽  
M. Perol ◽  
...  

Lung Cancer ◽  
2002 ◽  
Vol 38 (2) ◽  
pp. 193-197 ◽  
Author(s):  
Robert J Downey ◽  
Kenneth K Ng ◽  
Mark G Kris ◽  
Manjit S Bains ◽  
Vincent A Miller ◽  
...  

Lung Cancer ◽  
2003 ◽  
Vol 40 (2) ◽  
pp. 221-226 ◽  
Author(s):  
Yuh-Min Chen ◽  
Reury-Perng Perng ◽  
Mei-Chun Chen ◽  
Chun-Ming Tsai ◽  
Jacqueline Ming-Liu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document